Adamou, Anastasia http://orcid.org/0000-0003-4701-0858
Chlorogiannis, David Dimitris http://orcid.org/0000-0003-1596-9466
Kyriakoulis, Ioannis G. http://orcid.org/0000-0003-2970-088X
Stamatiou, Iliana
Koukousaki, Despoina
Kardoutsos, Ioannis
Sagris, Dimitrios
Doehner, Wolfram http://orcid.org/0000-0001-7598-708X
Ntaios, George http://orcid.org/0000-0002-0629-9248
Funding for this research was provided by:
University of Thessaly Central Library
Article History
Received: 18 September 2023
Accepted: 8 January 2024
First Online: 14 February 2024
Declarations
:
: The authors declare they have no conflict of interest.
: George Ntaios reports advisory boards/research support/speaker fees from Abbott; Amgen; AstraZeneca; Bayer; BMS; Boehringer Ingelheim; Javelin; Novartis; Pfizer; Sanofi.W. Doehner reports consulting fees from Aimediq, Bayer, Boehringer Ingelheim, Boston Scientific, Lilly, Medtronic, Pfizer, Sanofi-Aventis, Sphingotec, Vifor Pharma, travel support from Pharmacosmos, and research support to the Institute from EU (Horizon2020), German Ministry of Education and Research, German Center for Cardiovascular Research, Boehringer Ingelheim, Vifor Pharma, and ZS Pharma.